PixarBio Corp. To Establish Medical Research Center-Corporate Headquarters In Medford, Massachusetts
Located in close proximity to its innovation roots at Harvard and MIT, PixarBio Corp. said it will have capacity to quickly expand beyond biomaterials needed for Parkinson’s disease to include biomaterials for Epilepsy.
“We are building a home for our world renowned and award winning team of researchers to drive innovation and accelerate the development of new treatment options for Parkinson’s disease. We’re confident that our optimized R&D model will generate key intellectual property permitting PixarBio to lead the development of next generation biomaterials for the treatment of Parkinson’s disease as well as a range of chronic neurological conditions,” says CTO Randy Holmes-Farley, PhD.
Frank Reynolds, PixarBio’s CEO adds, “We’ll move to Medford, MA in early 2014 and get to work on achieving our objective of rapidly bringing a new Parkinson’s treatment to market. Along the way we’ll explore M&A in the biomaterials space while focusing on expanding our platform.”
Leonardo Wins Contract to Resupply Navy Helicopters at Santa Rosa County, Florida Air Station
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
Hot Jobs: Growing Industrial Sectors
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
What Should High-Growth Companies Look for in a Community?
A Tale of Demographics